We have previously reported that transforming growth factor (TGF)-beta in 2 the cerebrospinal fluid (CSF) is involved in the mechanism underlying the regulation of 3 spontaneous motor activity (SMA) by the central nervous system after exercise. 4
7
oxidation. 1 2 allowed 1 week to recover, and only animals with body weights greater than before 11 surgery were used. On the day of an experiment, 5 µg anti-TGF-beta or control 12 preimmune antibodies (R&D Systems, Minneapolis, MN) dissolved in 10 µL artificial 13 cerebrospinal fluid (a-CSF; 140 mM NaCl, 3.35 mM KCl, 1.2 mM Na 2 PO 4 , 0.3 mMSaline was administered as a control. 1 2
Vagotomy 3
After anesthetization with an i.p. injection of 1 mg/kg pentobarbital sodium, 4 rats were vagotomized as described by Li and Anderson [24] . In brief, a 5-cm midline 5 incision was made in the abdomen to expose the stomach and lower esophagus. 6
Thereafter, the bilateral vagal trunks were exposed and cut. A similar procedure was 7 carried out during sham surgery, except that the vagal trunks were not damaged. Rats 8 were allowed 2 weeks to recover from surgery. Because vagotomy decreases food 9 intake for 2 weeks [24] , operations were judged successful in rats whose food intake 10 decreased for at least 2 weeks. Rats that failed to regain pre-operation body weight were 11 excluded from subsequent experiments. There was an interval of at least 1 week 12 between each SMA experiment. Firstly, SMA was determined after the i.p. 13 administration of saline, and then the effects of i.p. administration of MA (400 µmol/kg 14 B.W.) and 2-DG (400 mg/kg B.W.) on SMA were determined. Finally, SMA was 15 determined in the untreated state. This sequence of experiment was not randomized, butwe confirmed the last administration of inhibitors did not affect the next basal counts of 1 SMA after one-week interval. CSF was collected from freshly vagotomized rats after a 2 2 week recovery period, as described above. 3 4
Statistical analysis 5
All data are expressed as mean ± S.E.M. Data in Figures 1B, 1D , 2, and 5 6 were analyzed using Student's t test. Data in Figure 3A were analyzed using a two-way 7 analysis of variance (ANOVA), and there was a significant interaction between i.c. and 8 i.p. administration. The data were then analyzed using one-way ANOVA, followed by 9 multiple comparison testing using a post-hoc Tukey's multiple comparison test. Data in 10 Figure 3B were analyzed using a two-way ANOVA, and there was no significant 11 interaction between i.c. and i.p. administration. The data were then analyzed using a 12
Student's t test in the same factor. Data in Figure 4 were analyzed using a one-way 13 ANOVA, followed by multiple comparison testing using a post-hoc Tukey's multiple 14 comparison test. P values of 5% or less were considered statistically significant. Prism 15
Results 1

Effect of i.p. administration of MA and 2-DG on SMA 2
Firstly, we investigated whether the inhibition of FA oxidation depressed 3 SMA similarly to exercise [20] or TGF-beta i.c. administration [20, 42] . We carried out 4 SMA measurements after inhibition of FA oxidation by MA i.p. administration. 5
Time-course changes in SMA over 60 min, 2 h after i.p. administration of MA (400 6 µmol/kg B.W.), are presented in Figure 1A . The cumulative SMA value in the MA 7 group was significantly lower than that in the saline group (Fig. 1B , P = 0.0036). To 8 compare the effect of MA with another metabolic inhibitor, we tested whether 2-DG 9 alters SMA in rats. Time-course changes in SMA over 60 min, 2 h after i.p. 10 administration of 2-DG (400 mg/kg B.W.), are presented in Figure 1C . The cumulative 11 SMA value in the 2-DG group was significantly lower than that in the saline group (Fig.  12 1D, P < 0.0001). 13 14
Effect of i.p. administration of MA and 2-DG on CSF TGF-beta levels 15
To address whether these metabolic inhibitors activate TGF-beta in CSF, wenext measured TGF-beta levels in CSF after MA or 2-DG administration. Two hours 1 after i.p. administration, the TGF-beta level in the CSF of rats given MA (400 µmol/kg 2 B.W.) was significantly higher than that in rats given saline ( Fig. 2A , P = 0.0295). In 3 contrast, there was no significant difference between TGF-beta levels in the CSF 2 h 4 after i.p. administration in rats given 2-DG (400 mg/kg B.W.) and rats given saline ( To determine whether increased TGF-beta in the CSF is required for 10 decreased SMA after administration of MA, we tested whether i.c. administered 11 anti-TGF-beta antibody eliminated the effect of MA on SMA. Previously, we had 12 demonstrated that i.c. anti-TGF-beta antibody administration completely abolished the 13 physiological effect of TGF-beta in the CSF [18, 19] . There was a statistically 14 significant interaction between i.c. anti-TGF-beta antibody administration and i.p. MA 15 administration ( Fig. 3A , P = 0.026). The cumulative SMA value over 60 min in thecontrol group that received preimmune antibody was significantly lower than that in the 1 group that had received the anti-TGF-beta antibody (Fig 3A, P < 
Effect of vagotomy on CSF TGF-beta levels after intraperitoneal administration of 5
MA 6
Finally, we tested whether vagotomy reversed the increase in TGF-beta 7 produced by i.p. MA administration. In vagotomized rats, there was no significant 8 difference between CSF TGF-beta levels in the i.p. MA and i.p. saline groups (Fig. 5A , 9 P = 0.371). In sham-operated rats, the TGF-beta level in the CSF was significantly 10 higher in animals that had received i.p. MA than in those that had received saline ( Fig.  11 5B, P = 0.0467). In the untreated state, there was no significant difference between
Discussion 1
In this study, we demonstrated that the FA oxidation inhibitor, MA, activated 2 TGF-beta in the CSF via the vagus nerve. Decreased SMA after exercise might prevent 3 further undesirable energy exhaustion in animals and allow restoration of energy stores. 4
The brain collects peripheral metabolic information and coordinates animal behavior to 5 maintain energy homeostasis [29, 36] . Thus, the decrease in SMA after exercise may not 6 only result from the exhaustion of energy stores and potential damage in peripheral 7 tissues but might also reflect a process that is more actively regulated by the CNS. The 8 entire mechanism by which SMA is decreased after exercise by the CNS is still poorly 9 understood; however, our reports [14,20,21,42] together with the results obtained in this 10 study highlight that TGF-beta in the CSF plays a crucial role in the mechanism 11 underlying the regulation of behavior by the CNS after exercise. 12
It has previously been unclear what physiological conditions trigger the 13 activation of TGF-beta in the CSF during exercise. We focused on the unique metabolic 14 alteration which is observed as a relative shortage of energy derived from FA oxidation 15 in the early phase of exercise [12, 33] . We then hypothesized that the shortage of energyderived from FA oxidation activated TGF-beta in the CSF. As expected, the inhibition 1 of FA oxidation activated TGF-beta in the CSF (Fig. 2) . To rule out of the possibility 2 that the activation of TGF-beta in the CSF by inibition of FA oxidation is observed only 3 in MA administration, we measured TGF-beta levels in the CSF after i.p. administration 4 of etomoxir, another inhibitor of FA oxidation. Etomoxir also activated TGF-beta in the 5 CSF (Supplement Figure 1) . Additionally a decrease in locomotor activity by 6 administration of etomoxir is already shown [16] . Therefore, the activation of TGF-beta 7 in the CSF and the subsequent decrease in SMA surely result from the inihibtion of FA 8 oxidation. The inhibition of carbohydrate oxidation, on the other hand, did not activate 9 TGF-beta in the CSF (Fig 2) . Taking into consideration that i.c. administration of 10 TGF-beta increases FA oxidation [42], TGF-beta in the CSF is involved in a 11 counter-regulatory system that responds to decreased FA oxidation. We showed that i.c. 12 administration of anti-TGF-beta antibody prevented the depressive effect of i.p. 13 administration of MA on SMA (Fig. 3) . This indicates that the activation of TGF-beta in 14 the CSF is required for the depression of SMA induced by inhibition of FA oxidation. 15
Taken together, our data suggest that the physiological condition that activates In conclusion, we have demonstrated that i.p. administration of MA, which 7 inhibits FA oxidation, induces decreased SMA in rats. This effect of MA administration 8 is transmitted via the vagus nerve and mediated by TGF-beta in the CSF. Impaired FA 9 oxidation has been reported to lead to decreased SMA [16] . In addition, carnitine is an 10 essential substance for beta-oxidation of FA and a decrease in SMA observed in fasting 11 carnitine-deficient mice [25] can be rescued by carnitine administration [43] . This 12 report also suggests a relationship between a reduction in energy supplied by FA 13 oxidation and a decrease in SMA. Taking other studies into consideration, inhibition of 14
FA oxidation strongly appears to lead to down-regulation of locomotor activity via the 15 liver-vagus nerve-brain system. Our data suggest that TGF-beta in the CSF plays a24 crucial role in this mechanism. 
